CROs
TECH OUTLOOK
ClinActis
Bringing the Western CRO Mindset to Asia
A
s a CRO ace in Asia, ClinActis has been providing
international clinical research expertise for almost
a decade now. With a western mindset based
in Asia, the company stands out as the experts
of international quality standards in Asia, provided in a
cost-effective way. Leveraging a combined experience of
over three decades of the team, ClinActis has an extensive
network of investigator sites in Asia. The majority of
CROs operating in Asia are global, and most often, global
CROs in Asia are fairly expensive and lack experience or
proximity with the local markets. Consequently they are
unable to deliver results on a timely basis. Local CROs in
We understand our international
clients’ needs, and the role of
djusted to client-
ClinActis can be adjusted
m full service to just
specific needs from
one specific task
Asia are only present in one orr two countries, which
limits their reach, and they lack
ck understanding
of international quality standards.
ards. ClinActis, on
the other hand, provides cost-effective
-effective solutions
with its experienced Project Managers that
can effectively manage risks, especially when
it comes to timelines for patient
ent recruitment
because the company recruits the right profiles
with the adequate experience. “Risks linked
to timelines for patient recruitment
tment need to be
managed with methods specific fic to the region,
which we are well experienced d in. There is also
specific support needed in order
der to ensure patient
enrollment as per objectives, and at ClinActis, all
professionals are able to deal with this aspect in a cost-
effective manner,” says Christophe
ophe Tournerie, CEO of
ClinActis.
The company provides a comprehensive set of
services, from strategic consulting,
ting, monitoring, site
management, regulatory and IRB submission, project
management, medical monitoring, ring, data management
(EDC), medical writing, PV to biostatistics. ClinActis
Christophe Tournerie
IN APAC - 2019
can also do the mapping of any clinical trial, whatever the
indication, the phase of the study and the client’s budget
constraints. As an expert in clinical research activities in
Asian countries, the company is well versed with the pros
and cons of each country. “We understand our international
clients’ needs, and the role of ClinActis can be adjusted to
client-specific needs from full service to just one specific
task,” explains Tournerie. He further says, “Globally, we are a
mid-size CRO, but in Asia, we have a solid presence in each
of the countries we cover, compared to large global CROs
who have minimal presence in each of the Asian countries.”
In addition, ClinActis understands how staff turnover
in a project team impacts the quality of the study. This is
the reason the company employs numerous strategies to
ensure staff satisfaction by understanding and managing
the expectations of staff, especially in a culturally diverse
environment as Asia. ClinActis provides the relevant
technical and soft skills training to ensure staff can perform
to the best of their
thei abilities and mentors the staff to
enable them to de develop their careers within their growing
organization.
organizatio
Over the years, the company has worked
with numerous
num clients and delivered successful
outcomes.
outcome In an instance, for a global phase III
study in Europe,
E U.S., and Asia, in colorectal cancer,
3 Asian
As countries were the first to recruit
patients
pa globally. To support the study,
ClinActis
C was able to recruit 70 percent of
the
th global patient target from Asia itself.
Moving forward, ClinActis plans to
continue
c and expand its presence in the
region with legal entities in China, Japan,
and Australia. The company also plans
to develop in-house new technologies,
as well as expand its palette of services
such as patient recruitment services.
“We are growing through alliances with
networks of CROs in order to offer global
coverage
c thanks to regional experts in each
region,
region to compete with global CROs,” adds
Tournerie.
Tourn The company has recently concluded
an alliance
alli called ACROSS with a group of
CROs,
CROs covering 52 countries in total. With this,
the company
co is starting to propose joint global
clinical
clinica services to the industry which will work
as a one-stop
on shop.